Literature DB >> 2154320

Prognostic factors after hepatectomy for hepatocellular carcinomas. A univariate and multivariate analysis.

N Yamanaka1, E Okamoto, A Toyosaka, M Mitunobu, S Fujihara, T Kato, J Fujimoto, T Oriyama, K Furukawa, E Kawamura.   

Abstract

The current study determines the prognostic factors after hepatectomy for hepatocellular carcinomas. The 295 patients who underwent hepatectomy from 1973 through 1987 were included for a univariate and a Cox multivariate analysis. The favoring conditions were determined as follows. The essential requirements are (1) the absence of tumor thrombi; (2) no intrahepatic metastasis, but even when present, it should be close to the main tumor and removed with a massive resection; and (3) retention rate of indocyanine green dye (ICG) at 15 minutes should be within 14 +/- 4.2% (M +/- SD) to allow that resection. The desired requirement is that the tumor size should preferably be less than 5 cm; a wider free margin from tumors (greater than or equal to 1 cm) is recommended, but not determining factor. The eligible patients, having no thrombi, no intrahepatic metastasis, a tumor size of 5 cm or less, negative surgical margin (greater than or equal to 1 cm), had achieved a 5-year survival of 78%. In conclusion, resection therapy is the first option for patients with those requirements.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2154320     DOI: 10.1002/1097-0142(19900301)65:5<1104::aid-cncr2820650511>3.0.co;2-g

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  53 in total

1.  Micrometastases of solitary hepatocellular carcinoma and appropriate resection margin.

Authors:  Ming Shi; Chang-Qing Zhang; Ya-Qi Zhang; Xiao-Man Liang; Jin-Qing Li
Journal:  World J Surg       Date:  2004-03-17       Impact factor: 3.352

2.  Effect of arterial administration of a high molecular weight anti-tumor agent, styrene maleic acid neocarzinostatin, for multiple small liver cancer--a pilot study.

Authors:  K Ikeda; S Saitoh; Y Suzuki; A Tsubota; I Koida; M Kobayashi; Y Arase; K Chayama; N Murashima; H Kumada
Journal:  J Gastroenterol       Date:  1997-08       Impact factor: 7.527

3.  Prognostic impact of anatomic resection for hepatocellular carcinoma.

Authors:  Kiyoshi Hasegawa; Norihiro Kokudo; Hiroshi Imamura; Yutaka Matsuyama; Taku Aoki; Masami Minagawa; Keiji Sano; Yasuhiko Sugawara; Tadatoshi Takayama; Masatoshi Makuuchi
Journal:  Ann Surg       Date:  2005-08       Impact factor: 12.969

4.  Hepatectomy for huge hepatocellular carcinoma in 634 cases.

Authors:  Xiao-Ping Chen; Fa-Zu Qiu; Zai-De Wu; Bi-Xiang Zhang
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

5.  Radiation therapy for portal venous invasion by hepatocellular carcinoma.

Authors:  Keiichi Nakagawa; Hideomi Yamashita; Kenshiro Shiraishi; Naoki Nakamura; Masao Tago; Hiroshi Igaki; Yoshio Hosoi; Shuichiro Shiina; Masao Omata; Masatoshi Makuuchi; Kuni Ohtomo
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

6.  Factors associated with disease survival after surgical resection in Chinese patients with hepatocellular carcinoma.

Authors:  Li Qiang; Li Huikai; Kelly Butt; P Peter Wang; Xishan Hao
Journal:  World J Surg       Date:  2006-03       Impact factor: 3.352

7.  Hepatic resection for small hepatocellular carcinoma: the Queen Mary Hospital experience.

Authors:  E C Lai; I O Ng; K T You; S T Fan; F P Mok; E S Tan; J Wong
Journal:  World J Surg       Date:  1991 Sep-Oct       Impact factor: 3.352

8.  Therapeutic results of computed-tomography-guided transcatheter arterial chemoembolization for local recurrence of hepatocellular carcinoma after initial transcatheter arterial chemoembolization: the results of 85 recurrent tumors in 35 patients.

Authors:  Mikio Tezuka; Keiji Hayashi; Yoichi Okada; Tetsuya Irie; Hiroyasu Ina
Journal:  Dig Dis Sci       Date:  2008-07-23       Impact factor: 3.199

9.  Fucosylated fraction of alpha-fetoprotein as a predictor of prognosis in patients with hepatocellular carcinoma after curative treatment.

Authors:  Yasushi Tamura; Masato Igarashi; Takeshi Suda; Toshifumi Wakai; Yoshio Shirai; Takeji Umemura; Eiji Tanaka; Satoru Kakizaki; Hitoshi Takagi; Yoichi Hiasa; Morikazu Onji; Yutaka Aoyagi
Journal:  Dig Dis Sci       Date:  2010-07       Impact factor: 3.199

10.  Randomized study of chemoembolization as an adjuvant therapy for primary liver carcinoma after hepatectomy.

Authors:  J Q Li; Y Q Zhang; W Z Zhang; Y F Yuan; G H Li
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.